TAX-TORC: A phase I trial of vistusertib (AZD2014) in combination with weekly paclitaxel with integrated pharmacodynamic (PD) and molecular characterization (MC) studies.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Raghav Sundar, Bristi Basu, Richard H. Wilson, James F. Spicer, Robert Hugh Jones, Matthew Krebs, Michael Brada, Denis Charles Talbot, Nicola Steele, Emma Hall, Holly Tovey, Suzanne Carreira, Flavia M de Oliveira, Karen E Swales, Geetha Balarajah, Joanna C Dawes, Mona Parmar, Johann S. De Bono, Udai Banerji
Institutions: Institute of Cancer Research, Royal Marsden Hospital, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Queen's University Belfast, King's College London, Velindre Cancer Centre, Cardiff University, University of Manchester, The Christie NHS Foundation Trust, University of Liverpool, Oxford University Hospitals NHS Trust, Beatson West of Scotland Cancer Centre
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2695219720